Study of Magrolimab Combinations in Participants With Myeloid Malignancies
Stopped early · Phase 2
Conditions studied: Myeloid Malignancies
In brief
The goal of this clinical study is to learn more about the safety and dosing of the study drug, magrolimab (Mag), in combination with anti-leukemia therapies in participants with acute myeloid leukemia (AML).
Key facts
- Study ID
- NCT04778410
- Run by
- Gilead Sciences
- People needed
- 54
- Starts
- 2021-06-28
- Expected to finish
- 2024-03-04
- Last updated by the study team
- 2025-03-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Alabama at Birmingham — Birmingham, Alabama, United States
- City of Hope (City of Hope National Medical Center, City of Hope Medical Center) — Duarte, California, United States
- USC/Norris Comprehensive Cancer Center — Los Angeles, California, United States
- Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute — Los Angeles, California, United States
- Stanford Cancer Center — Palo Alto, California, United States
- Sylvester Comprehensive Cancer Center — Miami, Florida, United States
- The University of Chicago Medical Center — Chicago, Illinois, United States
- Karmanos Cancer Institute — Detroit, Michigan, United States
- Washington University School of Medicine — St Louis, Missouri, United States
- Roswell Park Cancer Institute — Buffalo, New York, United States
- Levine Cancer Institute — Charlotte, North Carolina, United States
- Cleveland Clinic Foundation — Cleveland, Ohio, United States
- OU Health, Stephenson Cancer Center — Oklahoma City, Oklahoma, United States
- Baylor University Medical Center — Dallas, Texas, United States
- MD Anderson Cancer Center — Houston, Texas, United States
- Swedish Cancer Institute — Seattle, Washington, United States
- Froedtert Hospital & the Medical College of Wisconsin — Milwaukee, Wisconsin, United States
- Austin Health — Heidelberg, Victoria, Australia
- The Alfred Hospital — Melbourne, Victoria, Australia
- Royal Perth Hospital — Perth, Western Australia, Australia
- Oxford University Hospitals NHS Foundation Trust, Churchill Hospital — Oxford, United Kingdom
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.